Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology

Connie M. Weaver, B. R. Martin, G. S. Jackson, G. P. McCabe, J. R. Nolan, L. D. McCabe, S. Barnes, S. Reinwald, M. E. Boris, Munro Peacock

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Introduction: Reduction of ovarian estrogen secretion at menopause increases net bone resorption and leads to bone loss. Isoflavones have been reported to protect bone from estrogen deficiency, but their modest effects on bone resorption have been difficult to measure with traditional analytical methods. Methods: In this randomized-order, crossover, blinded trial in 11 healthy postmenopausal women, wecompared four commercial sources of isoflavones from soy cotyledon, soy germ, kudzu, and red clover and a positive control of oral 1 mg estradiol combined with 2.5 mg medroxyprogesterone or 5 mg/d oral risedronate (Actonel®) for their antiresorptive effects on bone using novel 41Ca methodology. Results: Risedronate and estrogen plus progesterone decreased net bone resorption measured by urinary 41Ca by 22 and 24%, respectively (P<0.0001). Despite serum isoflavone profiles indicating bioavailability of the phytoestrogens, only soy isoflavones from the cotyledon and germ significantly decreased net bone resorption by 9% (P = 0.0002) and 5% (P = 0.03), respectively. Calcium absorption and biochemical markers of bone turnover were not influenced by interventions. Conclusions: Dietary supplements containing genistein-like isoflavones demonstrated a significant but modest ability to suppress net bone resorption in postmenopausal women at the doses supplied in this study over a 50-d intervention period.

Original languageEnglish
Pages (from-to)3798-3805
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume94
Issue number10
DOIs
StatePublished - 2009

Fingerprint

Phytoestrogens
Isoflavones
Bone Resorption
Estradiol
Bone
Estrogens
Cotyledon
Bone and Bones
Medroxyprogesterone
Pueraria
Trifolium
Genistein
Bone Remodeling
Menopause
Dietary Supplements
Cross-Over Studies
Biological Availability
Progesterone
Dietary supplements
Biomarkers

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology. / Weaver, Connie M.; Martin, B. R.; Jackson, G. S.; McCabe, G. P.; Nolan, J. R.; McCabe, L. D.; Barnes, S.; Reinwald, S.; Boris, M. E.; Peacock, Munro.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 10, 2009, p. 3798-3805.

Research output: Contribution to journalArticle

Weaver, Connie M. ; Martin, B. R. ; Jackson, G. S. ; McCabe, G. P. ; Nolan, J. R. ; McCabe, L. D. ; Barnes, S. ; Reinwald, S. ; Boris, M. E. ; Peacock, Munro. / Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 10. pp. 3798-3805.
@article{89b115296d8d4cb59eaae69ab93fe7de,
title = "Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology",
abstract = "Introduction: Reduction of ovarian estrogen secretion at menopause increases net bone resorption and leads to bone loss. Isoflavones have been reported to protect bone from estrogen deficiency, but their modest effects on bone resorption have been difficult to measure with traditional analytical methods. Methods: In this randomized-order, crossover, blinded trial in 11 healthy postmenopausal women, wecompared four commercial sources of isoflavones from soy cotyledon, soy germ, kudzu, and red clover and a positive control of oral 1 mg estradiol combined with 2.5 mg medroxyprogesterone or 5 mg/d oral risedronate (Actonel{\circledR}) for their antiresorptive effects on bone using novel 41Ca methodology. Results: Risedronate and estrogen plus progesterone decreased net bone resorption measured by urinary 41Ca by 22 and 24{\%}, respectively (P<0.0001). Despite serum isoflavone profiles indicating bioavailability of the phytoestrogens, only soy isoflavones from the cotyledon and germ significantly decreased net bone resorption by 9{\%} (P = 0.0002) and 5{\%} (P = 0.03), respectively. Calcium absorption and biochemical markers of bone turnover were not influenced by interventions. Conclusions: Dietary supplements containing genistein-like isoflavones demonstrated a significant but modest ability to suppress net bone resorption in postmenopausal women at the doses supplied in this study over a 50-d intervention period.",
author = "Weaver, {Connie M.} and Martin, {B. R.} and Jackson, {G. S.} and McCabe, {G. P.} and Nolan, {J. R.} and McCabe, {L. D.} and S. Barnes and S. Reinwald and Boris, {M. E.} and Munro Peacock",
year = "2009",
doi = "10.1210/jc.2009-0332",
language = "English",
volume = "94",
pages = "3798--3805",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology

AU - Weaver, Connie M.

AU - Martin, B. R.

AU - Jackson, G. S.

AU - McCabe, G. P.

AU - Nolan, J. R.

AU - McCabe, L. D.

AU - Barnes, S.

AU - Reinwald, S.

AU - Boris, M. E.

AU - Peacock, Munro

PY - 2009

Y1 - 2009

N2 - Introduction: Reduction of ovarian estrogen secretion at menopause increases net bone resorption and leads to bone loss. Isoflavones have been reported to protect bone from estrogen deficiency, but their modest effects on bone resorption have been difficult to measure with traditional analytical methods. Methods: In this randomized-order, crossover, blinded trial in 11 healthy postmenopausal women, wecompared four commercial sources of isoflavones from soy cotyledon, soy germ, kudzu, and red clover and a positive control of oral 1 mg estradiol combined with 2.5 mg medroxyprogesterone or 5 mg/d oral risedronate (Actonel®) for their antiresorptive effects on bone using novel 41Ca methodology. Results: Risedronate and estrogen plus progesterone decreased net bone resorption measured by urinary 41Ca by 22 and 24%, respectively (P<0.0001). Despite serum isoflavone profiles indicating bioavailability of the phytoestrogens, only soy isoflavones from the cotyledon and germ significantly decreased net bone resorption by 9% (P = 0.0002) and 5% (P = 0.03), respectively. Calcium absorption and biochemical markers of bone turnover were not influenced by interventions. Conclusions: Dietary supplements containing genistein-like isoflavones demonstrated a significant but modest ability to suppress net bone resorption in postmenopausal women at the doses supplied in this study over a 50-d intervention period.

AB - Introduction: Reduction of ovarian estrogen secretion at menopause increases net bone resorption and leads to bone loss. Isoflavones have been reported to protect bone from estrogen deficiency, but their modest effects on bone resorption have been difficult to measure with traditional analytical methods. Methods: In this randomized-order, crossover, blinded trial in 11 healthy postmenopausal women, wecompared four commercial sources of isoflavones from soy cotyledon, soy germ, kudzu, and red clover and a positive control of oral 1 mg estradiol combined with 2.5 mg medroxyprogesterone or 5 mg/d oral risedronate (Actonel®) for their antiresorptive effects on bone using novel 41Ca methodology. Results: Risedronate and estrogen plus progesterone decreased net bone resorption measured by urinary 41Ca by 22 and 24%, respectively (P<0.0001). Despite serum isoflavone profiles indicating bioavailability of the phytoestrogens, only soy isoflavones from the cotyledon and germ significantly decreased net bone resorption by 9% (P = 0.0002) and 5% (P = 0.03), respectively. Calcium absorption and biochemical markers of bone turnover were not influenced by interventions. Conclusions: Dietary supplements containing genistein-like isoflavones demonstrated a significant but modest ability to suppress net bone resorption in postmenopausal women at the doses supplied in this study over a 50-d intervention period.

UR - http://www.scopus.com/inward/record.url?scp=70349918167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349918167&partnerID=8YFLogxK

U2 - 10.1210/jc.2009-0332

DO - 10.1210/jc.2009-0332

M3 - Article

VL - 94

SP - 3798

EP - 3805

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -